《大行報告》瑞信:理想汽車-W(02015.HK)上月銷售符指引 疫情下仍創新高
瑞信發表報告指,理想汽車-W(02015.HK)(LI.US)去年12月的交付量在疫情爆發期間仍創下新高,認爲是歸功於公司在零部件供應鏈和車輛交付方面的出色執行能力。對理想(LI.US)目標價維持35美元,評級「跑贏大市」。
瑞信估計,至去年12月底,理想L9和L8訂單積壓量將分別超過1萬架和1.5萬架,或有助今年的銷售表現。據公司指引,理想L9和L8的可持續月度交付量分別爲8,000至1萬架,以及1萬至1.5萬架。公司亦將在2月8日推出旗艦SUV理想L7。因此該行預計公司今年的交付量將按年增長80%至24萬架。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.